← Leaderboards
Christie M Orschell
Indiana Univ-Purdue Univ At Indianapolis
$7,516,916
Attributed
$9,278,887
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $901.1K · FY2005–24$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$9,278,887 · 7
By mechanism
U01$5,609,893 · 2
R01$1,825,968 · 1
U19$1,159,032 · 1
UH3$450,000 · 1
UH2$149,622 · 1
S10$84,372 · 1
Top collaborators
- George Norbert Cox5 shared
- Louis M Pelus5 shared
Most similar at Indiana Univ-Purdue Univ At Indianapolis
Same institution · by research overlap
- Louis M Pelus$9,998,893
- Joseph R Dynlacht$3,042,476
Others in their field
Top investigators on “Hematopoietic Stem Cells”
- Mary M Horowitz · Medical College Of Wisconsin$222,127,419
- Hans-Peter Kiem · Fred Hutchinson Cancer Center$80,540,126
- David T Scadden · Massachusetts General Hospital$40,987,034
- David A Williams · Indiana Univ-Purdue Univ At Indianapolis$36,503,708
- Irving Lerner Weissman · Stanford University$36,281,548
- Bruce R. Blazar · University Of Minnesota$33,175,355
Research focus
Hematopoietic Stem CellsHematopoieticRadiationHematopoiesisCessation Of LifeRecoveryTissuesBaseAnimal ModelElderlyAffectHematopoietic SystemFda ApprovedHemorrhageCsf3 GeneResponseNational Institute Of Allergy And Infectious DiseaseCellsBone MarrowProgramsAdultRadiation ToxicityGrantAnimals
Grant awards (26)
Development of dmPGE2 and Bcl-xl-targeting senolytics as medical countermeasures for H-ARS and DEARE$222,239
U19 · FY2024 · AI · contact PI
Development of dmPGE2 and Bcl-xl-targeting senolytics as medical countermeasures for H-ARS and DEARE$217,049
U19 · FY2023 · AI · contact PI
Extending the scope of PLX-R18 for H-ARS: efficacy in special populations and DEARE$502,589
U01 · FY2022 · AI · contact PI
Development of dmPGE2 and Bcl-xl-targeting senolytics as medical countermeasures for H-ARS and DEARE$230,093
U19 · FY2022 · AI · contact PI
Extending the scope of PLX-R18 for H-ARS: efficacy in special populations and DEARE$507,999
U01 · FY2021 · AI · contact PI
Development of dmPGE2 and Bcl-xl-targeting senolytics as medical countermeasures for H-ARS and DEARE$238,276
U19 · FY2021 · AI · contact PI
Extending the scope of PLX-R18 for H-ARS: efficacy in special populations and DEARE$518,282
U01 · FY2020 · AI · contact PI
Development of dmPGE2 and Bcl-xl-targeting senolytics as medical countermeasures for H-ARS and DEARE$251,375
U19 · FY2020 · AI · contact PI
Age-Related Differences in Response to Radiation and Medical Countermeasures$131,435
UH3 · FY2020 · AI · contact PI
Extending the scope of PLX-R18 for H-ARS: efficacy in special populations and DEARE$628,096
U01 · FY2019 · AI · contact PI
Age-Related Differences in Response to Radiation and Medical Countermeasures$148,496
UH3 · FY2019 · AI · contact PI
Extending the scope of PLX-R18 for H-ARS: efficacy in special populations and DEARE$528,607
U01 · FY2018 · AI · contact PI
Age-Related Differences in Response to Radiation and Medical Countermeasures$170,069
UH3 · FY2018 · AI · contact PI
Long-acting growth factors for treating the acute and long term effects of lethal$476,768
U01 · FY2017 · AI
Age-Related Differences in Response to Radiation and Medical Countermeasures$97,541
UH2 · FY2017 · AI · contact PI
Long-acting growth factors for treating the acute and long term effects of lethal$674,036
U01 · FY2016 · AI
Age-Related Differences in Response to Radiation and Medical Countermeasures$52,081
UH2 · FY2016 · AI · contact PI
Long-acting growth factors for treating the acute and long term effects of lethal$553,403
U01 · FY2015 · AI
Long-acting growth factors for treating the acute and long term effects of lethal$731,319
U01 · FY2014 · AI
Long-acting growth factors for treating the acute and long term effects of lethal$488,794
U01 · FY2013 · AI
BioPlex 200 System with High Throughput Fluidics (HTF) Multiplex Array System$84,372
S10 · FY2010 · RR · contact PI
Multifaceted Interventions to Amplify HSC Engraftment$359,123
R01 · FY2009 · HL · contact PI
Multifaceted Interventions to Amplify HSC Engraftment$359,123
R01 · FY2008 · HL · contact PI
Multifaceted Interventions to Amplify HSC Engraftment$359,123
R01 · FY2007 · HL · contact PI
Multifaceted Interventions to Amplify HSC Engraftment$369,849
R01 · FY2006 · HL · contact PI
Multifaceted Interventions to Amplify HSC Engraftment$378,750
R01 · FY2005 · HL